Carvedilol is widely metabolized in the liver and is not recommended in patients with hepatic impairment. Acute renal failure and renal abnormalities have been reported in patients with heart failure who also suffered from diffuse vascular disease and/or renal impairment. The risk of hypotension may be reduced by taking carvedilol with food to decrease the rate of absorption.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign Out
